UNSPSC 51273900: Combination anesthetics and adjuncts

This classification denotes combination drugs that consist of various combined compounds that are a) agents that are capable of inducing a total or partial loss of sensation, especially tactile sensation and pain, known as ANESTHETICS; and/or b) agents that enhance, modify, or modulate said anesthetics, agents generally known as ADJUNCTS. Typical combination anesthetic and adjunct constituents are articaine, benzocaine, bupivacaine, dibucaine, and lidocaine.

UNSPSC 51273900 Combination anesthetics and adjuncts is a Class code that in recent state and local procurement activity encompasses naloxone products, generic multi-source pharmaceuticals, over-the-counter medications, and direct-to-manufacturer prescription programs serving health departments, state pharmacy benefit programs, and cooperative purchasing alliances. State and local governments buy these products through a mix of issuing bodies: county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), and regional cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The procurement activity reflects both emergency-response and routine-supply acquisition, with products distributed through authorized wholesalers or directly to end-use facilities on quarterly or contract-term schedules.

Recent activity concentrates in Florida, Texas, and Minnesota. Seminole County, Florida issued an IFB (Solicitation IFB60459723LAS, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building, requiring electronic bid submission through the county e-Procurement Portal and a two-year initial contract term with one-year renewal option. The Texas Health and Human Services Commission posted a Request for Information (RFI HHS0017013, due April 3, 2026) to solicit vendor capabilities for a direct-to-manufacturer prescription program aimed at improving fulfillment efficiency and cost management outside traditional pharmacy benefit manager and group purchasing organization channels. MMCAP, administered by the Minnesota Department of Administration, issued an RFP (Solicitation S1070000015802, due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities in Minnesota and Oregon, requiring vendors to supply through three authorized wholesalers with cGMP and Drug Supply Chain Security Act compliance, pricing weighted 75 percent in evaluation, and a two-year initial term effective July 1, 2026.